ECSP055584A - Proceso para la preparación de fibrinógeno - Google Patents

Proceso para la preparación de fibrinógeno

Info

Publication number
ECSP055584A
ECSP055584A EC2005005584A ECSP055584A ECSP055584A EC SP055584 A ECSP055584 A EC SP055584A EC 2005005584 A EC2005005584 A EC 2005005584A EC SP055584 A ECSP055584 A EC SP055584A EC SP055584 A ECSP055584 A EC SP055584A
Authority
EC
Ecuador
Prior art keywords
preparation process
fibrinogen preparation
fibrinogen
purification
processes
Prior art date
Application number
EC2005005584A
Other languages
English (en)
Inventor
Sarah Kingsland
Robert Clemmitt
David Evans
Peter Feldman
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Publication of ECSP055584A publication Critical patent/ECSP055584A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención describe el uso de cromatografía de afinidad de iones metálicos inmovilizados para la separación de fibrinógeno de plasminógeno, para la purificación de fibrinógeno y por lo menos otra proteína, por ejemplo plasminógeno, y para la co-purificación de fibrinógeno y el factor XIII.
EC2005005584A 2002-07-10 2005-02-02 Proceso para la preparación de fibrinógeno ECSP055584A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0216001.8A GB0216001D0 (en) 2002-07-10 2002-07-10 Process and composition

Publications (1)

Publication Number Publication Date
ECSP055584A true ECSP055584A (es) 2005-07-06

Family

ID=9940203

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005584A ECSP055584A (es) 2002-07-10 2005-02-02 Proceso para la preparación de fibrinógeno

Country Status (17)

Country Link
US (1) US7816495B2 (es)
EP (1) EP1519944B1 (es)
JP (1) JP4324102B2 (es)
AT (1) ATE449104T1 (es)
AU (1) AU2003244850B2 (es)
BR (1) BRPI0312521B8 (es)
CA (1) CA2491716C (es)
DE (1) DE60330146D1 (es)
DK (1) DK1519944T3 (es)
EC (1) ECSP055584A (es)
ES (1) ES2332780T3 (es)
GB (1) GB0216001D0 (es)
IL (1) IL165988A0 (es)
MX (1) MXPA05000395A (es)
NO (1) NO20050091L (es)
PL (1) PL210616B1 (es)
WO (1) WO2004007533A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
WO2006021584A2 (en) 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
JP5086093B2 (ja) * 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド 組換え型ヒトｘｉｉｉ因子の精製
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101067131B (zh) * 2007-04-30 2011-08-17 华南理工大学 一种利用亲和层析法分离纯化纤溶酶的方法
WO2009130181A2 (en) * 2008-04-21 2009-10-29 Novo Nordisk Health Care Ag Dry transglutaminase composition
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CN106046147B (zh) 2010-09-20 2019-11-19 欧克塔医药公司 纤维蛋白原生产方法
EP2825555B1 (en) 2012-03-13 2017-07-12 Octapharma AG Mproved process for production of fibrinogen and fibrinogen produced thereby
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
AU2016354030B2 (en) 2015-11-09 2022-09-15 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US10695395B2 (en) * 2015-12-23 2020-06-30 Phoenix Tissue Repair, Inc. Collagen 7 compositions and methods of using the same
MX2019012347A (es) 2017-04-17 2020-01-15 Univ Colorado Regents Optimizacion de terapia de reemplazo enzimatico para el tratamiento de la homocistinuria.
SG11202003793WA (en) 2017-10-30 2020-05-28 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN116744986A (zh) 2020-12-25 2023-09-12 广州倍绣生物技术有限公司 纤维蛋白原除菌过滤
US20240342253A1 (en) 2021-08-13 2024-10-17 Biotest Ag Fibrinogen compositions and methods of preparation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618784B1 (fr) 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5445958A (en) 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors
JPH02193913A (ja) 1989-01-20 1990-07-31 Denki Kagaku Kogyo Kk パイロジエンを除去する方法
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5792835A (en) 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
WO1994002183A1 (en) 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
JPH06138127A (ja) 1992-10-26 1994-05-20 Tanabe Seiyaku Co Ltd 標識フィブリノーゲンおよびその用途
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
AU695266B2 (en) 1994-03-18 1998-08-13 Baxter International Inc. Topical fibrinogen complex
JPH0812586A (ja) 1994-07-01 1996-01-16 Mikimoto Pharmaceut Co Ltd 抗プラスミン剤
GB9424732D0 (en) 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
JPH08333387A (ja) 1995-06-12 1996-12-17 Mitsubishi Materials Corp タンパク質分離精製方法
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US5981254A (en) 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
AUPP521298A0 (en) 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
JP2001270900A (ja) 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法

Also Published As

Publication number Publication date
PL210616B1 (pl) 2012-02-29
AU2003244850B2 (en) 2009-06-25
US20070042944A1 (en) 2007-02-22
US7816495B2 (en) 2010-10-19
JP2006505508A (ja) 2006-02-16
BRPI0312521B8 (pt) 2021-05-25
IL165988A0 (en) 2006-01-15
MXPA05000395A (es) 2005-09-30
DE60330146D1 (de) 2009-12-31
NO20050091L (no) 2005-04-06
WO2004007533A1 (en) 2004-01-22
PL374080A1 (en) 2005-09-19
BRPI0312521B1 (pt) 2019-06-25
ATE449104T1 (de) 2009-12-15
CA2491716C (en) 2012-02-07
JP4324102B2 (ja) 2009-09-02
EP1519944B1 (en) 2009-11-18
EP1519944A1 (en) 2005-04-06
CA2491716A1 (en) 2004-01-22
BR0312521A (pt) 2005-04-19
DK1519944T3 (da) 2010-03-29
GB0216001D0 (en) 2002-08-21
AU2003244850A1 (en) 2004-02-02
ES2332780T3 (es) 2010-02-12

Similar Documents

Publication Publication Date Title
ECSP055584A (es) Proceso para la preparación de fibrinógeno
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
BR0113286A (pt) Pirazóis substituìdos
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20091976L (no) Nye forbindelser
ID23374A (id) Halogenopirimidin
TW200505875A (en) Novel compounds
GB0111186D0 (en) Novel compounds
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
DE69938935D1 (de) Zyklische conotoxin-peptide
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE422498T1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
GB0216002D0 (en) Process and composition
EA200601219A1 (ru) Новые конденсированные пирролокарбазолы
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
EA200400438A1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной гипертонии
MXPA03010498A (es) Proceso para la preparacion de imipenem.